Literature DB >> 24100398

Transplantation: Donor-derived skin cancer in a kidney transplant recipient.

Jean Kanitakis1, Sylvie Euvrard.   

Abstract

Skin carcinomas, triggered by ultraviolet light, commonly develop post-transplantation and are associated with substantial morbidity and mortality. A recent study in kidney transplant recipients has shown that some of these tumours arise from donor-derived cells. This phenomenon is interesting for the study of carcinogenesis, although its effect on clinical practice is unknown.

Entities:  

Mesh：

Year:  2013        PMID： 24100398     DOI： 10.1038/nrneph.2013.211

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

Review 1.  Skin cancers after organ transplantation.

Authors:  Sylvie Euvrard; Jean Kanitakis; Alain Claudy
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

2.  Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery.

Authors:  Rona M MacKie; Robin Reid; Brian Junor
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

3.  Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.

Authors:  Martin Körbling; Ruth L Katz; Abha Khanna; Arnout C Ruifrok; Gabriela Rondon; Maher Albitar; Richard E Champlin; Zeev Estrov
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 4.  Donor cell leukemia: insight into cancer stem cells and the stem cell niche.

Authors:  Catherine M Flynn; Dan S Kaufman
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

5.  Skin carcinoma arising from donor cells in a kidney transplant recipient.

Authors:  Sélim Aractingi; Jean Kanitakis; Sylvie Euvrard; Caroline Le Danff; Isabelle Peguillet; Kiarash Khosrotehrani; Olivier Lantz; Edgardo D Carosella
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

6.  A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population.

Authors:  C A Harwood; D Mesher; J M McGregor; L Mitchell; M Leedham-Green; M Raftery; R Cerio; I M Leigh; P Sasieni; C M Proby
Journal:  Am J Transplant       Date:  2012-10-16       Impact factor: 8.086

7.  Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors.

Authors:  Patrizia Barozzi; Mario Luppi; Fabio Facchetti; Cristina Mecucci; Milena Alù; Ronit Sarid; Valeria Rasini; Luisa Ravazzini; Elisa Rossi; Silvana Festa; Barbara Crescenzi; Dana G Wolf; Thomas F Schulz; Giuseppe Torelli
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

8.  Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation.

Authors:  Anne Janin; Hideyuki Murata; Christophe Leboeuf; Jean-Michel Cayuela; Eliane Gluckman; Luc Legrès; Allison Desveaux; Mariana Varna; Philippe Ratajczak; Jean Soulier; Hugues de Thé; Philippe Bertheau; Gérard Socié
Journal:  Blood       Date:  2008-12-05       Impact factor: 22.113

9.  Donor-derived keratinocytes in actinic keratosis and squamous cell carcinoma in patients with kidney transplant.

Authors:  Laurence Verneuil; Mariana Varna; Christophe Leboeuf; Louis François Plassa; Morad Elbouchtaoui; Irmine Loisel-Ferreira; Fatiha Bouhidel; Marie-Noelle Peraldi; Celeste Lebbé; Philippe Ratajczak; Anne Janin
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551

10.  Human skin carcinoma arising from kidney transplant-derived tumor cells.

Authors:  Laurence Verneuil; Mariana Varna; Philippe Ratajczak; Christophe Leboeuf; Louis-François Plassa; Morad Elbouchtaoui; Pierre Schneider; Wissam Sandid; Celeste Lebbé; Marie-Noelle Peraldi; François Sigaux; Hugues de Thé; Anne Janin
Journal:  J Clin Invest       Date:  2013-08-27       Impact factor: 14.808
  10 in total
  1 in total

Review 1.  Skin cancer in kidney transplant recipients.

Authors:  Claudio Ponticelli; David Cucchiari; PierLuca Bencini
Journal:  J Nephrol       Date:  2014-05-09       Impact factor: 4.393
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.